表紙
市場調查報告書

美容整形外科的全球市場:2019年∼2023年

Global Cosmetic Surgery Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 373405
出版日期 內容資訊 英文 119 Pages
訂單完成後即時交付
價格
Back to Top
美容整形外科的全球市場:2019年∼2023年 Global Cosmetic Surgery Market 2019-2023
出版日期: 2019年02月14日內容資訊: 英文 119 Pages
簡介

越來越多患有肥胖等疾病的人採用整形手術以去除不需要的體脂並改變和改善體形。身體部位有不必要的脂肪,抗飲食脂肪和運動抗性脂肪的人選擇整形手術。全世界肥胖症發病率的增加進一步導致對諸如吸脂術等外科手術的需求成長。許多肥胖的人選擇進行整形手術,例如持續吸脂減肥,改善或解決與肥胖相關的合併症,以及實現身體緊實和強壯肌肉的外觀。患有肥胖等疾病的人日益採用整形手術以改善他們的身體輪廓和比例,這促成了全球整形手術市場的顯著成長。供應商為提高人們對美容護理的信心而持續努力將推動市場成長。Technavio的分析師預測,到2023年,整形手術市場的年複合成長率將超過7%。

本報告提供全球美容整形外科市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 報告的範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各類型

  • 市場區隔:各類型
  • 各類型比較:市場規模及預測(2018年∼2023年)
  • 非外科手術
  • 外科手術
  • 市場機會:各類型

第7章 客戶形勢

第8章 地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 成長要素與課題

  • 市場成長要素
  • 市場課題

第10章 市場趨勢

  • 技術的進步
  • 專門美容整形手術的醫院及外科醫生的增加
  • 對審美性的治療的需求增加

第11章 業者情勢

  • 概要
  • 創造性破壞狀況

第12章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • ALLERGAN
  • Bausch Health
  • Galderma laboratories
  • Hologic Inc.
  • Merz Pharma

第13章 附錄

  • 調查方法
  • 簡稱的清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR30860

About this market

The increasing adoption of cosmetic surgeries among individuals who suffer from medical condition such as obesity in order to remove unwanted body fat and alter and improve the body shape. People with body parts that have unwanted fat, diet-resistant fat, and exercise-resistant fat are opting for cosmetic surgeries. The increasing incidence of obesity across the world has further led to growth in demand for surgical procedures such as liposuction. Many people who are obese are opting for cosmetic surgeries such as liposuction for sustained weight loss, to improve or resolve obesity-associated co-morbidities, and to achieve a trim body and athletic looks. The increased adoption of cosmetic procedures by people suffering from medical conditions such as obesity with the aim of improving their body contours and proportion has contributed to the significant growth of the global cosmetic surgery market. Such increasing efforts by vendors to create confidence among people to undergo cosmetic treatments will drive market growth. Technavio's analysts have predicted that the cosmetic surgery market will register a CAGR of over 7% by 2023.

Market Overview

Increasing demand for minimally invasive and non-invasive cosmetic surgeries

Minimal invasive and non-invasive alternatives have been increasingly gaining popularity in cosmetic surgery. Minimally invasive cosmetic surgery involves the use of techniques that cause less damage to the body when compared with conventional procedures such as open surgeries.

Risk of complications during cosmetic implant procedures

Cosmetic implant surgery involves potential risks that can lead to complications and result in an outcome that is contrary to the intended purpose. A major risk associated with cosmetic surgeries includes issues related to general anesthesia, which could result in a reaction that can be fatal, lead to bleeding, infection, and blood clots or cause fatal cardiovascular complications, such as a heart attack, deep vein thrombosis or a stroke.

For the detailed list of factors that will drive and challenge the growth of the cosmetic surgery market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fairly concentrated and with the presence of few vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • Non-surgical procedures - Market size and forecast 2018-2023
  • Surgical procedures - Market size and forecast 2018-2023
  • Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

  • Technological advances
  • Growing number of hospitals and surgeons specializing in cosmetic surgery
  • Rising demand for aesthetic procedures

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • ALLERGAN
  • Bausch Health
  • Galderma laboratories
  • Hologic Inc.
  • Merz Pharma

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ billions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Type - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by type
  • Exhibit 19: Non-surgical procedures - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 20: Non-surgical procedures - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Surgical procedures - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 22: Surgical procedures - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Market opportunity by type
  • Exhibit 24: Customer landscape
  • Exhibit 25: Market share by geography 2018-2023 (%)
  • Exhibit 26: Geographic comparison
  • Exhibit 27: North America - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 29: Europe - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 30: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Asia - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 32: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: ROW - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 34: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Key leading countries
  • Exhibit 36: Market opportunity
  • Exhibit 37: Impact of drivers and challenges
  • Exhibit 38: Vendor landscape
  • Exhibit 39: Landscape disruption
  • Exhibit 40: Vendors covered
  • Exhibit 41: Vendor classification
  • Exhibit 42: Market positioning of vendors
  • Exhibit 43: ALLERGAN - Vendor overview
  • Exhibit 44: ALLERGAN - Business segments
  • Exhibit 45: ALLERGAN - Organizational developments
  • Exhibit 46: ALLERGAN - Segment focus
  • Exhibit 47: ALLERGAN - Key offerings
  • Exhibit 48: Bausch Health - Vendor overview
  • Exhibit 49: Bausch Health - Business segments
  • Exhibit 50: Bausch Health - Organizational developments
  • Exhibit 51: Bausch Health - Geographic focus
  • Exhibit 52: Bausch Health - Segment focus
  • Exhibit 53: Bausch Health - Key offerings
  • Exhibit 54: Galderma laboratories - Vendor overview
  • Exhibit 55: Galderma laboratories - Business segments
  • Exhibit 56: Galderma laboratories - Organizational developments
  • Exhibit 57: Galderma laboratories - Key offerings
  • Exhibit 58: Hologic Inc. - Vendor overview
  • Exhibit 59: Hologic Inc. - Business segments
  • Exhibit 60: Hologic Inc. - Organizational developments
  • Exhibit 61: Hologic Inc. - Geographic focus
  • Exhibit 62: Hologic Inc. - Segment focus
  • Exhibit 63: Hologic Inc. - Key offerings
  • Exhibit 64: Merz Pharma - Vendor overview
  • Exhibit 65: Merz Pharma - Product segments
  • Exhibit 66: Merz Pharma - Organizational developments
  • Exhibit 67: Merz Pharma - Geographic focus
  • Exhibit 68: Merz Pharma - Key offerings
  • Exhibit 69: Validation techniques employed for market sizing
Back to Top